PATENT CLAIM ANALYSIS

Application Number: 16067630
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "054000"]

Abstract:
One aspect of the present invention is directed to conjugates that comprise a linear polymer carrier, a linker and one or more drugs or imaging agents, as well as pharmaceutical compositions that include such conjugates. The drug may be a platinum-containing drug with a linker comprised of a modified amino acid. The conjugate may alternatively include a metal complexing ligand with a metal used for imaging or chemotherapeutic purposes. Another aspect of the invention is directed to formulations and processes for lyophilization of hyaluronan conjugates. Another aspect of the invention is directed to methods for treating and/or inhibiting cancer utilizing the conjugates and compositions described herein.

Claim (Index 24):
The process of any of  claims 20 - 23 , wherein the hyaluronan-drug conjugate is a hyaluronan-platinum conjugate.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.76562
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12363302', '13140347', '10779186', '14406938', '15722831']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7794868963302364
- 35 USC 102 Novelty (BERT): 0.4949218676753603
- Combined Prediction Score: 0.7510303934647489
- Mean Citation Score: 233.10567000000003
- Max Citation Score: 242.62738
- Similarity Product: 187.73269116118664

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test